Press Releases

Date	Title
April 28, 2022	Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
April 7, 2022	Corcept Therapeutics Announces Appointment of Three Senior Leaders
April 4, 2022	Corcept Therapeutics Completes Enrollment in Phase 2 GRATITUDE Study of Miricorilant in Patients with Antipsychotic-Induced Weight Gain
March 30, 2022	Relacorilant Plus Nab-Paclitaxel Extends Survival in Women with Recurrent, Platinum-resistant Ovarian Cancer
March 1, 2022	Corcept Therapeutics to Host Ovarian Cancer Program Update on Thursday, March 31, 2022
February 15, 2022	Corcept Therapeutics Announces Fourth Quarter and Full-Year 2021 Audited Financial Results and Provides Corporate Update
February 8, 2022	Corcept Therapeutics to Announce Fourth Quarter and Full-year 2021 Financial Results, Provide Corporate Update and Host Conference Call